✦ LIBER ✦

Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial

✍ Scribed by Thomas Elter; Liana Gercheva-Kyuchukova; Halyna Pylylpenko; Tadesuz Robak; Branimir Jaksic; Grigoriy Rekhtman; Sławomira Kyrcz-Krzemień; Mykola Vatutin; Jingyang Wu; Cynthia Sirard; Michael Hallek; Andreas Engert

Book ID: 117785782
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 286 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70242-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab Plus Fludarabine and Cyclophos

Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia

✍ Robak, T.; Dmoszynska, A.; Solal-Celigny, P.; Warzocha, K.; Loscertales, J.; Cat 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 282 KB

Assessment of fludarabine plus cyclophos

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

✍ D Catovsky; S Richards; E Matutes; D Oscier; MJS Dyer; RF Bezares; AR Pettitt; T 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 157 KB

Addition of rituximab to fludarabine and

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

✍ M Hallek; K Fischer; G Fingerle-Rowson; AM Fink; R Busch; J Mayer; M Hensel; G H 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 309 KB

A randomized phase II trial of fludarabi

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

✍ Peter Hillmen; Dena R. Cohen; Kim Cocks; Andrew Pettitt; Hazem A. Sayala; Andy C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Health-Related Quality of Life in Younge

✍ Eichhorst, B. F.; Busch, R.; Obwandner, T.; Kuhn-Hallek, I.; Herschbach, P.; Hal 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 191 KB

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO